Fundraising Fox
Kodiak Sciences
NASDAQ: KODPalo Alto, US · Delaware corporation
Find your way into Kodiak Sciences
Each arrow is one introduction. Sign up to fill in the first one.
257 people can intro you to John
Ask Julie Grant to introduce you to John Borgeson
You →Julie · together at LABRYS BIOLOGICS, INC. →John
Sign up to find every way you can get introduced to Kodiak Sciences
- Your email: who you already know at Kodiak Sciences, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Kodiak Sciences team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Kodiak Sciences develops biopharmaceutical therapies for chronic ophthalmic diseases, with a focus on patient outcomes and stakeholder impact in the healthcare system.
Founders & leadership
JB
John BorgesonExecutive Vice President, Chief Financial OfficerJohn Borgeson is an Executive Officer at Kodiak Sciences, a biopharmaceutical company developing therapies for chronic ophthalmic diseases. He brings over twenty years of experience in finance and leadership across global and early-stage organizations, with expertise in strategic planning, business development, capital formation, and financial operations including SEC reporting and regulatory compliance.
Reported raises · per SEC filings
Form D private placements$34M disclosed across 1 round · 2015
▶$34MraisedMar 2016 · 13 investors · BiotechnologyRule 506(b)
▶$34MraisedMar 2016 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John BorgesonExecutive Officer
- Offering amount
- $34M
- Amount sold
- $34M
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Seeking AlphaSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
NasdaqNasdaq operates a technology infrastructure platform for financial markets across three business segments: Capital Access Platforms (which includes listing services, indices, and analytics tools), Financial Technology (comprising compliance, regulatory, and capital markets software), and Market Services (equities and derivatives trading operations). The company serves financial institutions, listed companies, investment managers, and regulatory agencies globally.
Companies working in the same space as Kodiak Sciences.
Frequently asked questions
- What does Kodiak Sciences do?
- Kodiak Sciences develops biopharmaceutical therapies for chronic ophthalmic diseases, with a focus on patient outcomes and stakeholder impact in the healthcare system.
- Who founded Kodiak Sciences?
- Kodiak Sciences was founded by Victor Perlroth.
- How much funding has Kodiak Sciences raised?
- Kodiak Sciences has disclosed $34M raised across 1 round.
- Where is Kodiak Sciences headquartered?
- Kodiak Sciences is headquartered in Palo Alto, US.